ANDREA CHAFFIN: Open Payments
NPI 1649995861 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 86 payments from 13 companies in 2025. Trend: 2023 $461 · 2024 $1,160 · 2025 $2,226
Food & beverage: $1,541Travel & lodging: $685
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $685 |
| ABBVIE INC. | 44 | $457 |
| Ipsen Biopharmaceuticals, Inc | 10 | $253 |
| Madrigal Pharmaceuticals | 5 | $222 |
| Janssen Scientific Affairs, LLC | 1 | $142 |
| Janssen Biotech, Inc. | 7 | $128 |
| Aimmune Therapeutics, Inc. | 5 | $120 |
| GENZYME CORPORATION | 3 | $64 |
| Lilly USA, LLC | 3 | $52 |
| Celltrion USA Inc. | 2 | $39 |
Products named: INTERSTIM, TREMFYA, IQIRVO, RINVOQ, REZDIFFRA, ZENPEP, LINZESS, DUPIXENT.
Industry payments across AR — which companies pay providers there.
